Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Adefovir dipivoxil is a prodrug form of the antiviral nucleoside analog adefovir (Item No. 18650).1 Adefovir dipivoxil inhibits hepatitis B virus (HBV) DNA synthesis in HepG2 2.2.15 cells infected with HBV (EC50 = 0.517 μM).2 It is cytotoxic to HepG2 2.2.15 cells with a 50% cytotoxicity concentration (CC50) value of 540 μM. Adefovir dipivoxil inhibits HBV replication in the liver of HBV transgenic mice (ED50 = 0.2 μmol/kg per day).3 Formulations containing adefovir dipivoxil have been used in the treatment of chronic HBV infection.
WARNING This product is not for human or veterinary use.
1. rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B. J. Viral Hepat. 17(Suppl. 1), 66-72 (2010).
2. Design and synthesis of novel bis(L-
3. Alkoxyalkyl esters of 9-